Wendy Short Bartie, Executive Vice President of Corporate Affairs at Bristol Myers Squibb, filed a Form 4 on September 3, 2026, disclosing the vesting of restricted stock units and a related tax-withholding disposition of common stock on September 1, 2026.
Key Highlights
- RSU vesting: 1,236 restricted stock units vested on September 1, 2026, each converting into one share of Bristol Myers Squibb common stock, $0.10 par value.
- Tax withholding disposal: 633 shares were disposed of at $66.92 per share to cover taxes upon vesting.
- Vesting schedule: According to the filing, the restricted stock units vested in four equal installments beginning on September 1, 2023.
- Post-transaction ownership: Following the transactions, Short Bartie directly beneficially owned 12,684 shares of common stock.
- Reporting person role: Short Bartie is identified in the filing as an officer with the title EVP, Corporate Affairs.
RSU Vesting and Share Withholding Details for Bristol Myers Squibb EVP
According to the Form 4 filed with the SEC on September 3, 2026, Wendy Short Bartie reported two transactions in Bristol Myers Squibb common stock (NYSE:BMY) dated September 1, 2026. The first transaction, coded "M," reflects the acquisition of 1,236 shares through the vesting of restricted stock units at a reported price of $66.92. The filing notes that each restricted stock unit converts into one share of common stock upon vesting.
The second transaction, coded "F," reflects the disposal of 633 shares at $66.92 per share. The filing explains this as shares withheld for payment of taxes upon vesting of the awards. Following both transactions, Short Bartie's direct beneficial ownership of Bristol Myers Squibb common stock stood at 12,684 shares, as reported in the filing.
The derivative securities table shows that the restricted stock units, which had a conversion or exercise price of $0, were fully settled in the September 1, 2026 vesting event, leaving 0 restricted stock units remaining. The filing was signed by Amy Fallone as attorney-in-fact for Wendy Short Bartie on September 3, 2026.
What Was Disclosed
The filing disclosed the vesting of 1,236 restricted stock units and the withholding of 633 shares for tax purposes by EVP Wendy Short Bartie on September 1, 2026, leaving her with direct beneficial ownership of 12,684 shares of Bristol Myers Squibb common stock.




Please wait processing your request...